172 related articles for article (PubMed ID: 34031157)
1. Survival of people with valvular heart disease in a large, English community-based cohort study.
Taylor CJ; Ordóñez-Mena JM; Jones NR; Roalfe AK; Myerson SG; Prendergast BD; Hobbs FR
Heart; 2021 Aug; 107(16):1336-1343. PubMed ID: 34031157
[TBL] [Abstract][Full Text] [Related]
2. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry.
Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.
Rezzoug N; Vaes B; de Meester C; Degryse J; Van Pottelbergh G; Mathei C; Adriaensen W; Pasquet A; Vanoverschelde JL
BMC Cardiovasc Disord; 2016 Jan; 16():7. PubMed ID: 26754575
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
[TBL] [Abstract][Full Text] [Related]
5. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
d'Arcy JL; Coffey S; Loudon MA; Kennedy A; Pearson-Stuttard J; Birks J; Frangou E; Farmer AJ; Mant D; Wilson J; Myerson SG; Prendergast BD
Eur Heart J; 2016 Dec; 37(47):3515-3522. PubMed ID: 27354049
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease.
Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y;
J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031
[TBL] [Abstract][Full Text] [Related]
7. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients.
Gardezi SKM; Myerson SG; Chambers J; Coffey S; d'Arcy J; Hobbs FDR; Holt J; Kennedy A; Loudon M; Prendergast A; Prothero A; Wilson J; Prendergast BD
Heart; 2018 Nov; 104(22):1832-1835. PubMed ID: 29794244
[TBL] [Abstract][Full Text] [Related]
8. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
[TBL] [Abstract][Full Text] [Related]
9. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.
Tung M; Nah G; Tang J; Marcus G; Delling FN
Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104095
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
[TBL] [Abstract][Full Text] [Related]
13. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.
Tan MC; Yeo YH; San BJ; Suleiman A; Lee JZ; Chatterjee A; Sell-Dottin KA; Sweeney JP; Fortuin FD; Lee KS
J Am Heart Assoc; 2024 Apr; 13(8):e030895. PubMed ID: 38587138
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
[TBL] [Abstract][Full Text] [Related]
15. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
16. Clinical information has low sensitivity for postmortem diagnosis of heart valve disease.
Coffey S; Harper AR; Cairns BJ; Roberts IS; Prendergast BD
Heart; 2017 Jul; 103(13):1031-1035. PubMed ID: 28183793
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
[TBL] [Abstract][Full Text] [Related]
18. Determinants of Bioprosthetic Aortic Valve Degeneration.
Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.
Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P
Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873
[TBL] [Abstract][Full Text] [Related]
20. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
De Caterina R; Renda G; Carnicelli AP; Nordio F; Trevisan M; Mercuri MF; Ruff CT; Antman EM; Braunwald E; Giugliano RP
J Am Coll Cardiol; 2017 Mar; 69(11):1372-1382. PubMed ID: 28302288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
